Iovance Biotherapeutics (IOVA) Misses Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- SanDisk upgraded at JPMorgan after investor day; shares climb
Iovance Biotherapeutics (IOVA) Halted on LUDP
February 25, 2020 1:18 PM ESTIovance Biotherapeutics (NASDAQ: IOVA) Halted on LUDP
... MoreUPDATE: Iovance Biotherapeutics (IOVA) Said to Explore Potential Sale - Bloomberg
February 25, 2020 1:17 PM EST(Updated - February 25, 2020 1:21 PM EST)
Iovance Biotherapeutics (NASDAQ: IOVA) is exploring a sale and held preliminary talks with potential buyers, according to Bloomberg, citing people familiar with the matter.
It is working with a financial adviser after receiving takeover interest.
... More